Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1520262/000152026218000026/alks-20180331x10q.htm
|
Alkermes Contacts: | ||
|
For Investors: |
Sandy Coombs |
+1 781 609 6377 |
|
|
Eva Stroynowski |
+1 781 609 6823 |
|
For Media: |
Jennifer Snyder |
+1 781 609 6166 |
Alkermes Plc Reports First Quarter 2018 Financial Results
First Quarter Revenues Increase to $225.2 Million, Primarily Driven by 20% Year-Over-Year Growth of Proprietary Product Net Sales
Company Reports GAAP Net Loss per Share of $0.40 and Non-GAAP Net Loss per Share of $0.09
ALKS 5461 NDA Accepted for Regulatory Review;
Assigned Jan. 31, 2019 PDUFA Date
Company Updating Financial Expectations for 2018
DUBLIN, Ireland, Apr. 26, 2018 Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2018.
Our first quarter results were in line with our expectations and reflect the solid growth of our proprietary commercial products and the continued strength of our royalty and manufacturing business, commented James Frates, Chief Financial Officer of Alkermes. Today, we are updating our financial expectations for 2018, driven primarily by the timing of investments we will make in our commercial organization in preparation for the potential launch of ALKS 5461 in 2019. We remain well positioned to execute on our strategy to drive long-term value through important investments in our development pipeline and the growth of VIVITROL® and ARISTADA®.
Quarter Ended Mar. 31, 2018 Financial Highlights
· Total revenues for the quarter were $225.2 million. This compared to $191.8 million for the same period in the prior year, representing an increase of 17%.
· Net loss according to generally accepted accounting principles in the U.S. (GAAP) was $62.5 million for the quarter, or a basic and diluted GAAP net loss per share of $0.40. This compared to GAAP net loss of $68.9 million, or a basic and diluted GAAP net loss per share of $0.45 for the same period in the prior year.
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alkermes Plc..
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1520262/000152026218000026/alks-20180331x10q.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years